Next Generation News and Research

RSS

GE Healthcare-Glaxo Smith Kline deal to create force in cancer testing

A recently announced deal between GE Healthcare-subsidiary Clarient and Glaxo Smith Kline will create a force in cancer testing, according to Kalorama Information. The healthcare market research publisher tracks companion products, and says that the two entities will form a multi-purpose, data analytics- and companion diagnostics-driven network of laboratories. Kalorama Information recently released a market study, Companion Diagnostics Market, for companion diagnostics such as the drug-test combinations envisioned in this deal.

9 Oct 2014

HIMSS, AVIA announce new initiative to co-develop HX360 to improve health care delivery

Today, Healthcare Information and Management Systems Society and AVIA announced HX360, a new co-developed initiative. HX360 was created to improve the way that health care is delivered by both inspiring and facilitating the adoption and use of next generation (non-EHR Platform) technologies by provider organizations, in areas where health system executives are passionate to combine the right mix of resources, processes and technologies.

8 Oct 2014

GenomOncology, med fusion partner to optimize treatment strategies for tumor

med fusion, an integrated molecular center of excellence and clinical trials service organization and GenomOncology, an Ohio based genomics technology and services provider, today announced a partnership to optimize treatment strategies based on the patient's disease state and tumor profile.

8 Oct 2014

Picwell to analyze potential impact of latest decision support systems on consumer health plan selection

Picwell, the most advanced predictive recommendation engine for health plan selection, today announced finalized agreements to conduct studies focused on the potential impact of latest generation decision support systems on consumer health plan selection.

8 Oct 2014

'Achilles heel' in metabolic pathway could stop growth of lung cancer cells

Researchers at UT Southwestern Medical Center have found an "Achilles heel" in a metabolic pathway crucial to stopping the growth of lung cancer cells.

8 Oct 2014

MyCartis announces launch of digital multiplex biomarker analysis platform

MyCartis today announced the launch of Evalution, a multiplex biomarker analysis platform for the life sciences research market.

7 Oct 2014

New Aalborg University center to study link between maladaptive central nervous system, chronic pain

A new research center at Aalborg University in Denmark will investigate how a maladaptive central nervous system can be responsible for the enduring or chronic pain that affects one in five adult Danes. If this major ambition is fulfilled, it may turn the understanding of the pain system on its head and improve treatment.

7 Oct 2014

U-M scientists launch $11.5 million effort to better understand cause of Parkinson's disease

Deep in the brains of the million Americans with Parkinson's disease, changes to their brain cells put them at high risk of dangerous falls -- a problem that resists even the most modern treatments.

7 Oct 2014

Lucideon announces successful development of bioceramics for bone repair

As a partner in the EU-funded Bio-Bone project (Bioceramics for Bone Repair) Lucideon is pleased to announce that the pan-European consortium has successfully developed phosphate-glasses (p-glasses) with biomaterial properties for bone repair.

From Lucideon 3 Oct 2014

Exclusive partnership brings together next-generation proteomics and next-generation sequencing

AB SCIEX and Illumina (NASDAQ: ILMN) announced today the OneOmics™ project, an exclusive partnership to bring together SWATH™-based next-generation proteomics (NGP) and next-generation sequencing (NGS) tools in a cloud computing environment.

3 Oct 2014

NIH announces winners of BRAIN Initiative awards

Today the National Institutes of Health (NIH) announced their first round of BRAIN Initiative awards, and six teams from the Massachusetts Institute of Technology (MIT) are among the recipients.

1 Oct 2014

Virginia Tech professor wins Paul L. Busch Award for outstanding work in water quality research

Amy Pruden, professor of civil and environmental engineering at Virginia Tech, is the 2014 recipient of the Paul L. Busch Award, including a $100,000 research grant.

1 Oct 2014

Acutus Medical concludes additional $26.2M financing round to broaden its product portfolio

Acutus Medical, Inc. (ACM), a medical device company developing a minimally invasive real-time 3D Cardiac Chamber Imaging and Dipole Density Mapping system to identify the sources that cause and / or sustain complex cardiac arrhythmias, including atrial fibrillation, announced it has completed an additional $26.2M financing to continue developing its imaging/mapping system as well as bring to market a complete product portfolio.

30 Sep 2014

CMU's BrainHub initiative receives major boost from renowned Pittsburgh philanthropist

Just weeks after the launch of a global initiative to leverage its unique strengths to impact brain research, Carnegie Mellon University has received a major boost from renowned Pittsburgh philanthropist Henry L. Hillman in the form of a new $5 million gift to support CMU's BrainHub.

30 Sep 2014

VCU receives $6 million grant to develop safe, effective treatments for cocaine addiction

Virginia Commonwealth University has received a five-year, $6 million grant for clinical research and education directed toward the identification, evaluation and development of safe and effective treatments for cocaine addiction.

30 Sep 2014

Bausch + Lomb’s sub-micron loteprednol etabonate ophthalmic gel meets primary endpoint

Bausch + Lomb, a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX), today announced that its next generation sub-micron gel formulation of loteprednol etabonate was statistically superior to placebo (vehicle gel) in eliminating inflammation and pain following cataract surgery by study day eight, the primary endpoints in the first Phase 3, multi-center, double-masked, vehicle-controlled, parallel-group study.

30 Sep 2014

Finding ways to rejuvenate "immunological age" of the brain

How the brain ages is still largely an open question - in part because this organ is mostly insulated from direct contact with other systems in the body, including the blood and immune systems. In research that was recently published in Science, Weizmann Institute researchers Prof. Michal Schwartz of the Neurobiology Department and Dr. Ido Amit of Immunology Department found evidence of a unique "signature" that may be the "missing link" between cognitive decline and aging.

30 Sep 2014

Aptose joins Beat AML research collaboration

Aptose Biosciences Inc., a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer, the Knight Cancer Institute at Oregon Health & Science University and The Leukemia & Lymphoma Society today announced that Aptose has joined the Beat AML collaboration.

29 Sep 2014

Diplomat's clinical technology manager honored as finalist in 2014 Next-Generation Pharmacist awards

Diplomat, the nation's largest independent specialty pharmacy, is proud to announce that clinical technology manager Mike Crowe, PharmD, MBA, CSP, FMPA, was honored as a finalist in the 2014 Next-Generation Pharmacist awards.

29 Sep 2014

Agrisoma Biosciences closes Series A financing round

Agrisoma Biosciences Inc. an agriculture technology company, today announced the first closing of its Series A financing round, expected to total $8 million through 2014.

27 Sep 2014

Next Generation News and Research

GE Healthcare-Glaxo Smith Kline deal to create force in cancer testing

HIMSS, AVIA announce new initiative to co-develop HX360 to improve health care delivery

GenomOncology, med fusion partner to optimize treatment strategies for tumor

Picwell to analyze potential impact of latest decision support systems on consumer health plan selection

'Achilles heel' in metabolic pathway could stop growth of lung cancer cells

MyCartis announces launch of digital multiplex biomarker analysis platform

New Aalborg University center to study link between maladaptive central nervous system, chronic pain

U-M scientists launch $11.5 million effort to better understand cause of Parkinson's disease

Lucideon announces successful development of bioceramics for bone repair

Exclusive partnership brings together next-generation proteomics and next-generation sequencing

NIH announces winners of BRAIN Initiative awards

Virginia Tech professor wins Paul L. Busch Award for outstanding work in water quality research

Acutus Medical concludes additional $26.2M financing round to broaden its product portfolio

CMU's BrainHub initiative receives major boost from renowned Pittsburgh philanthropist

VCU receives $6 million grant to develop safe, effective treatments for cocaine addiction

Bausch + Lomb’s sub-micron loteprednol etabonate ophthalmic gel meets primary endpoint

Finding ways to rejuvenate "immunological age" of the brain

Aptose joins Beat AML research collaboration

Diplomat's clinical technology manager honored as finalist in 2014 Next-Generation Pharmacist awards

Agrisoma Biosciences closes Series A financing round

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News